Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8500)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Jan 28, 2020 (publication date) through Nov 28, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Cloyd JM, Tsung A, Hays J, Wills CE, Bridges JF. Neoadjuvant therapy for resectable pancreatic ductal adenocarcinoma: The need for patient-centered research. World J Gastroenterol 2020; 26(4): 375-382 [PMID: 32063686 DOI: 10.3748/wjg.v26.i4.375] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v26/i4/375.htm |
| Number | Citing Articles |
| 1 |
Dong-Qin Xia, Yong Zhou, Shuang Yang, Fang-Fei Li, Li-Ya Tian, Yan-Hua Li, Hai-Yan Xu, Cai-Zhi Xiao, Wei Wang. Combining prognostic value of serum carbohydrate antigen 19-9 and tumor size reduction ratio in pancreatic ductal adenocarcinoma. World Journal of Gastrointestinal Oncology 2024; 16(3): 798-809 doi: 10.4251/wjgo.v16.i3.798
Abstract(255) |
Core Tip(276) |
Full Article(HTML)(1092)
|
Full Article with Cover (PDF)-2130K(51)
|
Full Article (Word)-886K(7)
|
Audio-236K(0)
|
Peer-Review Report-261K(30)
|
Answering Reviewers-163K(43)
|
Full Article (PDF)-1863K(79)
|
Full Article (XML)-126K(36)
|
Times Cited (0)
|
Total Visits (3173)
|
Open
|
| 2 |
Zachary J. Brown, Hanna E. Labiner, Chengli Shen, Aslam Ejaz, Timothy M. Pawlik, Jordan M. Cloyd. Impact of care fragmentation on the outcomes of patients receiving neoadjuvant and adjuvant therapy for pancreatic adenocarcinoma. Journal of Surgical Oncology 2022; 125(2): 185 doi: 10.1002/jso.26706
|
| 3 |
Lena Stevens, Marissa Guo, Zachary J. Brown, Aslam Ejaz, Timothy M. Pawlik, Jordan M. Cloyd. Evaluating the Quality of Online Information Regarding Neoadjuvant Therapy for Pancreatic Cancer. Journal of Gastrointestinal Cancer 2023; 54(3): 890 doi: 10.1007/s12029-022-00879-z
|
| 4 |
Krist Aploks, Minha Kim, Stephanie Stroever, Alexander Ostapenko, Young Bo Sim, Ashwinkumar Sooriyakumar, Arash Rahimi-Ardabily, Ramanathan Seshadri, Xiang Da Dong. Radiation therapy prior to a pancreaticoduodenectomy for adenocarcinoma is associated with longer operative times and higher blood loss. World Journal of Gastrointestinal Surgery 2023; 15(8): 1663-1672 doi: 10.4240/wjgs.v15.i8.1663
Abstract(343) |
Core Tip(365) |
Full Article(HTML)(943)
|
Full Article with Cover (PDF)-1369K(50)
|
Full Article (Word)-178K(18)
|
Audio-800K(2)
|
Peer-Review Report-288K(37)
|
Answering Reviewers-199K(38)
|
Full Article (PDF)-810K(76)
|
Full Article (XML)-100K(44)
|
Times Cited (1)
|
Total Visits (3561)
|
Open
|
| 5 |
Ahmad Hamad, Norah Crossnohere, Aslam Ejaz, Allan Tsung, Timothy M. Pawlik, Angela Sarna, Heena Santry, Celia Wills, Jordan M. Cloyd. Patient Preferences for Neoadjuvant Therapy in Pancreatic Ductal Adenocarcinoma. Pancreas 2022; 51(6): 657 doi: 10.1097/MPA.0000000000002083
|
| 6 |
Christopher T. Aquina, Aslam Ejaz, Allan Tsung, Timothy M. Pawlik, Jordan M. Cloyd. National Trends in the Use of Neoadjuvant Therapy Before Cancer Surgery in the US From 2004 to 2016. JAMA Network Open 2021; 4(3): e211031 doi: 10.1001/jamanetworkopen.2021.1031
|
| 7 |
Elizabeth L. Carpenter, Spencer G. Van Decar, Patrick M. McCarthy, Franklin A. Valdera, Alexandra M. Adams, Anne E. O'Shea, Todd Smolinsky, Katryna Thomas, Guy T. Clifton, Timothy E. Newhook, George E. Peoples, Daniel W. Nelson, Timothy J. Vreeland. The benefit of adjuvant chemotherapy following pancreaticoduodenectomy for pancreatic adenocarcinoma depends on response to neoadjuvant therapy. Journal of Surgical Oncology 2024; 130(1): 109 doi: 10.1002/jso.27689
|
| 8 |
Natalie M. Bath, Angela Sarna, Marilly Palettas, Christina Monsour, Lena Stevens, Heena Santry, Aslam Ejaz, Alex Kim, Timothy Pawlik, Jordan M. Cloyd. Characterizing treatment burden during neoadjuvant therapy for patients with gastrointestinal cancer: A mixed methods analysis. Journal of Surgical Oncology 2023; 128(2): 393 doi: 10.1002/jso.27288
|
| 9 |
Zachary J. Brown, Jordan M. Cloyd. Trends in the utilization of neoadjuvant therapy for pancreatic ductal adenocarcinoma. Journal of Surgical Oncology 2021; 123(6): 1432 doi: 10.1002/jso.26384
|
| 10 |
Lena Stevens, Zachary J Brown, Ryan Zeh, Christina Monsour, Sharla Wells-Di Gregorio, Heena Santry, Aslam M Ejaz, Timothy Michael Pawlik, Jordan M Cloyd. Characterizing the patient experience during neoadjuvant therapy for pancreatic ductal adenocarcinoma: A qualitative study. World Journal of Gastrointestinal Oncology 2022; 14(6): 1175-1186 doi: 10.4251/wjgo.v14.i6.1175
|
| 11 |
Jordan M. Cloyd, Sarah Hyman, Tanya Huwig, Christina Monsour, Heena Santry, Celia Wills, Allan Tsung, John F. P. Bridges. Patient experience and quality of life during neoadjuvant therapy for pancreatic cancer: a systematic review and study protocol. Supportive Care in Cancer 2021; 29(6): 3009 doi: 10.1007/s00520-020-05813-2
|
| 12 |
Ahmad Hamad, Zachary J Brown, Aslam M Ejaz, Mary Dillhoff, Jordan M Cloyd. Neoadjuvant therapy for pancreatic ductal adenocarcinoma: Opportunities for personalized cancer care. World Journal of Gastroenterology 2021; 27(27): 4383-4394 doi: 10.3748/wjg.v27.i27.4383
|
| 13 |
Keisuke Taniuchi, Makoto Ueno, Tomoyuki Yokose, Masahiko Sakaguchi, Reiko Yoshioka, Mitsunari Ogasawara, Takuhiro Kosaki, Seiji Naganuma, Mutsuo Furihata, Surinder K. Batra. Upregulation of PODXL and ITGB1 in pancreatic cancer tissues preoperatively obtained by EUS-FNAB correlates with unfavorable prognosis of postoperative pancreatic cancer patients. PLOS ONE 2022; 17(3): e0265172 doi: 10.1371/journal.pone.0265172
|